Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02824055
What this trial is testing

Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics

Who this might be right for
Schizophrenia
Hoffmann-La Roche 33
Not applicableLooking for participantsNCT07343193
What this trial is testing

Deprescribing Antipsychotics: a Multiple Case Study

Who this might be right for
Psychotic Disorder
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT03116100
What this trial is testing

Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey

Who this might be right for
Behavior DisordersNeuroleptic
Centre Hospitalier Universitaire, Amiens 30
Not applicableUnknownNCT01057849
What this trial is testing

Standard Comprehensive Intervention to Treat First-episode Schizophrenia

Who this might be right for
Schizophrenia
Peking University 600
Not applicableStudy completedNCT04002258
What this trial is testing

Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment

Who this might be right for
SchizophreniaAntipyretics ToxicityProlactin Excess
Shanghai Mental Health Center 10,363
Not applicableEnded earlyNCT01894984
What this trial is testing

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 640
Post-approval studies (Phase 4)Study completedNCT01185743
What this trial is testing

Antipsychotics and Gene Expression in Soft Tissues

Who this might be right for
SchizophreniaDiabetes
Medical University of Vienna 16
Not applicableUnknownNCT03090490
What this trial is testing

10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Post-approval studies (Phase 4)Study completedNCT02515773
What this trial is testing

Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

Who this might be right for
Bipolar Disorder
Melissa Delbello 1,565
Large-scale testing (Phase 3)Study completedNCT00535574
What this trial is testing

Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 90
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Post-approval studies (Phase 4)Study completedNCT02704962
What this trial is testing

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

Who this might be right for
Schizophrenia
Kaohsiung Kai-Suan Psychiatric Hospital 94
Large-scale testing (Phase 3)Study completedNCT00149734
What this trial is testing

Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

Who this might be right for
Schizophrenia
University of Colorado, Denver 8
Not applicableLooking for participantsNCT06431009
What this trial is testing

The Danish Region Midt Schizophrenia Cohort

Who this might be right for
Schizophrenia
University of Aarhus 350
Not applicableStudy completedNCT00690365
What this trial is testing

Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 576
Post-approval studies (Phase 4)UnknownNCT05646264
What this trial is testing

A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms in Schizophrenia
Shanghai Mental Health Center 220
Post-approval studies (Phase 4)Study completedNCT00757705
What this trial is testing

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Taiwan Ltd 299
Post-approval studies (Phase 4)UnknownNCT00541554
What this trial is testing

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Who this might be right for
HyperprolactinemiaWeight GainDyslipidemia
Genovate Biotechnology Co., Ltd.,
Post-approval studies (Phase 4)Study completedNCT01085383
What this trial is testing

Aripiprazole and Prolactin Study

Who this might be right for
Hyperprolactinemia
University of Oxford 15
Testing effectiveness (Phase 2)UnknownNCT03369795
What this trial is testing

Add-on Methotrexate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Sheba Medical Center 100
Next Page